Welcome to our dedicated page for Nature’S Sun news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature’S Sun stock.
Nature’s Sunshine Products, Inc. reports company developments tied to its global natural health and wellness business, including herbal and nutritional supplements, personal care products, and its Synergy Worldwide division. News commonly covers quarterly results, gross margin and volume incentive trends, digital commerce, customer acquisition, auto-ship subscription programs, and performance across markets such as Asia, North America, Europe and Latin America.
Company updates also include executive appointments, supply chain and technology initiatives, and product-level announcements such as Pro-Argi-9+, Synergy’s L-arginine supplement for nitric oxide and circulation support.
Nature's Sunshine Products (Nasdaq: NATR) has converted its US manufacturing facility to 100% solar energy, achieving this milestone one year ahead of its ESG target. This switch decreases greenhouse gas emissions by 42%, supporting its broader goals of reducing emissions by 50% by 2025 and achieving zero waste to landfill at US distribution centers. CEO Terrence Moorehead emphasized the company's commitment to sustainability, while VP Trent McCausland expressed pride in this achievement and the ongoing efforts to meet further sustainability goals.
Nature’s Sunshine reported a net sales increase of 8% to $110.5 million for Q1 2022, a record for the company, despite challenges including COVID-19 and supply chain issues. However, the company faced a GAAP net loss of $(2.7 million) compared to a profit of $4.2 million in Q1 2021. Adjusted EBITDA fell to $8.2 million from $11.6 million.
Increased SG&A expenses were noted at $40.6 million. Inventory impairment charges totaled $4.2 million. Cash used in operating activities was $(7.9 million).
Nature's Sunshine Products (NASDAQ: NATR) has appointed Martin Gonzalez as the new Executive Vice President of Global Supply Chain, effective May 16, 2022. With over 30 years of experience at notable companies like Unilever and Molson Coors, Gonzalez is expected to enhance operational excellence and drive transformation within the company's supply chain. His leadership aims to support sustainable growth and expand Nature's Sunshine's global footprint. Gonzalez holds a Global MBA and has a solid track record in supply chain improvements.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on May 5, 2022, at 5:00 p.m. Eastern time to discuss its first-quarter financial results for 2022. CEO Terrence Moorehead and CFO Joseph Baty will present the results, followed by a Q&A session. Investors can join the call using the toll-free number 1-800-768-5121 or the international number 1-312-429-0440. A replay of the call will be available until May 19, 2022. Nature's Sunshine is a leading natural health and wellness company offering herbal and nutritional products globally.
Summary not available.
Summary not available.
Summary not available.
Nature’s Sunshine Products (Nasdaq: NATR) reported a 15.9% rise in Q4 2021 net sales to $117.9 million, marking its sixth consecutive quarter of record sales. Full-year net sales reached a record $444.1 million, up 15.3% from 2020. Fourth quarter GAAP net income soared 107.6% to $13.8 million, or $0.67 per share. Adjusted EBITDA increased 54.7% to $11.6 million. The company also announced a $30 million share repurchase program. While the company is optimistic about 2022, it noted potential risks to sales in regions affected by the Russian invasion of Ukraine.
Nature’s Sunshine Products (NASDAQ: NATR), a leader in natural health, will participate in two virtual financial conferences in March 2022. The D.A. Davidson’s 5th Annual Consumer Growth Conference will feature a fireside chat on March 10 at 3:30 p.m. ET, accessible via webcast. Additionally, NATR will attend the Sidoti Small Cap Conference on March 23, also in a virtual one-on-one format. Nature’s Sunshine distributes high-quality herbal and nutritional products globally, manufacturing most in their advanced facilities to ensure safety and efficacy.
Summary not available.